VASOVIST (gadofosveset trisodium injection for intravenous use) Injection has been administered to humans up to a dose of 0.15 mmol/kg (5 times the clinical dose). No VASOVIST (gadofosveset trisodium injection for intravenous use) overdoses were reported in clinical trials. In the event of an overdose, direct treatment toward the support of all vital functions and prompt institution of symptomatic therapy. Gadofosveset has been shown to be removed by hemodialysis using a high flux dialysis procedure [see CLINICAL PHARMACOLOGY].
History of a prior allergic reaction to a gadolinium-based contrast agent.
Last reviewed on RxList: 10/5/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Vasovist Information
Report Problems to the Food and Drug Administration
Find out what women really need.